matf-header

Monash Antibody Technologies Facility

MATF is a global source of cost effective, high quality, high affinity, custom monoclonal antibodies. Our team of highly skilled scientists employ well-established standard operating procedures, along with the latest robotic techniques, to deliver successful projects to customers in a typical time frame of 16-20 weeks. We are known for our ability to succeed at challenging projects and strive to be the best at producing monoclonal antibodies where others have failed.
MATF has a wealth of experience in other areas such as robotics, high throughput screening, antibody purification and characterization and are keen to help customers with antibody or laboratory automation challenges.
MATF will work with the customer at every step to ensure the needs of each individual project are met and is proud to follow a Quality Management System that is certified to ISO9001.

 


quick-quote-over

Latest News

Building functionality into the antibody supply chain

The Monash Antibody Technologies Facility is featured in the Tecan Journal

Read more...
 
MATF launches 2 new services

MATF can now offer antibody sequencing and cell-line banking and storage

Read more...
 
Celebrating our new robot

The Monash Antibody Technologies Facility celebrated the arrival of the new Tecan FluentTM cell-based screening system – the latest solution for functional antibody selection.

Read more...
 
ISO9001 certified!

In June 2015 MATF's Quality Management System was certifed to ISO9001.

Read more...
 
A step closer towards developing an allergen immunotherapy vaccine targeting subtropical grass pollens

MATF is collaborating with Dr. Janet Davies, an international leader in subtropical grass pollen research at The University of Queensland.

Read more...